Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about FTH1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
FTH1 is a protein involved in neurodegeneration research. Key relationships include: associated with, activates, inhibits. Associated with Aging, Als, Alzheimer. Connected to 155 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | FTH1 |
| Full Name | Ferritin Heavy Chain 1 |
| Chromosome | 19q13.33 |
| Protein Family | Ferritin heavy chain subunit |
| Function | is a hallmark of multiple neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[@ward2014]. |
| Molecular Weight | 21 kDa |
| Exons | 4 |
| Pathways | Apoptosis, Blood-Brain Barrier, Ferroptosis, Metastasis, Mitophagy |
| UniProt ID | P02794 |
| NCBI Gene ID | 2495 |
| Ensembl ID | ENSG00000196950 |
| OMIM | 134790 |
| GeneCards | FTH1 |
| Human Protein Atlas | FTH1 |
| Ferroxidase center | Located in FTH1, catalyzes Fe2+ -> Fe3+ oxidation |
| Associated Diseases | ALS, Carcinoma, Hepatocellular Carcinoma, Parkinson's disease, stroke, Tumor |
| Known Drugs/Compounds | dimethyl malonate, paricalcitol |
| Interactions | ACSL4, ACTB, ALZHEIMER, ALZHEIMER'S DISEASE, AMYLOID, AMYLOID-BETA |
| KG Connections | 319 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
FTH1["FTH1"]
FTH1 -->|"inhibits"| Ms["Ms"]
FTH1 -->|"inhibits"| Depression["Depression"]
FTH1 -->|"activates"| Fibrosis["Fibrosis"]
FTH1 -->|"activates"| Als["Als"]
FTH1 -->|"activates"| Parkinson["Parkinson"]
FTH1 -->|"inhibits"| Alzheimer["Alzheimer"]
TFR1["TFR1"] -->|"inhibits"| FTH1
BECLIN1["BECLIN1"] -->|"activates"| FTH1
GPX4["GPX4"] -->|"inhibits"| FTH1
NRF2["NRF2"] -->|"inhibits"| FTH1
ACSL4["ACSL4"] -->|"expressed in"| FTH1
APP["APP"] -->|"inhibits"| FTH1
SLC7A11["SLC7A11"] -->|"expressed in"| FTH1| Target | Relation | Type | Str |
|---|---|---|---|
| iron homeostasis | regulates | process | 0.90 |
| Ferroptosis | inhibits | pathway | 0.90 |
| Ferroptosis | associated_with | process | 0.85 |
| Iron storage | mediates | process | 0.85 |
| NCOA4 | inhibits | gene | 0.80 |
| FERROPTOSIS | inhibits | gene | 0.80 |
| NCOA4 | associated_with | gene | 0.80 |
| Autophagy | associated_with | pathway | 0.80 |
| Carcinoma | associated_with | disease | 0.75 |
| Alzheimer | inhibits | disease | 0.75 |
| Als | inhibits | disease | 0.75 |
| Colorectal Cancer | activates | disease | 0.75 |
| Cancer | activates | disease | 0.75 |
| Tumor | activates | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Hepatocellular Carcinoma | associated_with | disease | 0.75 |
| GPX4 | expressed_in | gene | 0.70 |
| ferroptosis | participates_in | pathway | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| PTGS2 | associated_with | gene | 0.70 |
| P62 | associated_with | gene | 0.70 |
| NCOA4 | activates | gene | 0.70 |
| Ferroptosis | activates | pathway | 0.70 |
| CANCER | activates | gene | 0.70 |
| Fibrosis | activates | disease | 0.65 |
| Depression | treats | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Alzheimer | treats | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Ischemia | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Depression | inhibits | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Fibrosis | biomarker_for | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Aging | treats | disease | 0.65 |
| Ischemia | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| SQSTM1 | activates | gene | 0.60 |
| FBXW7 | associated_with | gene | 0.60 |
| P53 | associated_with | gene | 0.60 |
| Ferroptosis | interacts_with | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| iron | binds | compound | 0.95 |
| GPX4 | associated_with | gene | 0.70 |
| SLC7A11 | associated_with | gene | 0.70 |
| SQSTM1 | associated_with | gene | 0.70 |
| ELAVL1 | associated_with | gene | 0.70 |
| BECN1 | associated_with | gene | 0.70 |
| COL1A1 | associated_with | gene | 0.70 |
| AUTOPHAGY | associated_with | gene | 0.70 |
| ROS | associated_with | gene | 0.70 |
| P62 | associated_with | gene | 0.70 |
| ATG | associated_with | gene | 0.70 |
| FERROPTOSIS | interacts_with | gene | 0.70 |
| APP | inhibits | gene | 0.60 |
| GPX4 | expressed_in | gene | 0.60 |
| SLC7A11 | expressed_in | gene | 0.60 |
| NRF2 | expressed_in | gene | 0.60 |
| PTGS2 | expressed_in | gene | 0.60 |
| BECLIN1 | inhibits | gene | 0.60 |
| TAU | inhibits | gene | 0.60 |
| IREB2 | expressed_in | gene | 0.60 |
| P62 | inhibits | gene | 0.60 |
| DMT1 | expressed_in | gene | 0.60 |
| JNK | inhibits | gene | 0.60 |
| DHODH | regulates | gene | 0.60 |
| FSP1 | regulates | gene | 0.60 |
| GPX4 | activates | gene | 0.60 |
| KEAP1 | regulates | gene | 0.60 |
| DMT1 | associated_with | gene | 0.60 |
| FN1 | associated_with | gene | 0.60 |
| ZFP36 | associated_with | gene | 0.60 |
| HO-1 | activates | gene | 0.60 |
| P53 | expressed_in | gene | 0.60 |
| OXIDATIVE STRESS | interacts_with | gene | 0.60 |
| C-JUN | associated_with | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| INFLAMMATION | inhibits | gene | 0.60 |
| ALZHEIMER'S DISEASE | inhibits | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | inhibits | gene | 0.60 |
| ROS | inhibits | gene | 0.60 |
| NEUROINFLAMMATION | inhibits | gene | 0.60 |
| LC3B | inhibits | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| ALZHEIMER | inhibits | gene | 0.60 |
| AMYLOID | inhibits | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| ACSL4 | expressed_in | gene | 0.60 |
| STROKE | activates | gene | 0.60 |
| TFR1 | expressed_in | gene | 0.60 |
| GPX4 | inhibits | gene | 0.60 |
| NRF2 | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-17 | 7 hypotheses Top: 0.685
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning FTH1 in their description or question text
No additional research found